Imipenem–cilastatin or meropenem may be included in the treatment of MDR/RR-TB patients
on longer regimens.
Guideline Citation
WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
Grade Certainty of evidence
Grade Strength
Grade Certainty of evidence label
Recommendation Direction